Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients

Kidney transplantation with hepatitis C viremic (dHCV+) donors appears safe for recipients without HCV when accompanied by direct acting antiviral (DAA) treatment. However, US programs have been reluctant to embrace this approach due to concern about insurance coverage. While the cost of DAA treatme...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transplant Direct
Asıl Yazarlar: Axelrod, David A., Lentine, Krista L., Balakrishnan, Ramji, Chang, Su-Hsin, Alhamad, Terek, Xiao, Huiling, Kasiske, Bertran L., Bloom, Roy D., Schnitzler, Mark A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2020
Konular:
Kidney Transplantation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7665247/
https://ncbi.nlm.nih.gov/pubmed/33204825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001056
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller